Description

Titan Retatrutide (RETA) represents the absolute frontier of metabolic research. Known as a “triple agonist,” it targets three distinct nutrient-stimulated hormone receptors: Glucagon-like peptide-1 (GLP-1), Glucose-dependent insulinotropic polypeptide (GIP), and Glucagon.

By activating all three pathways simultaneously, Retatrutide offers a synergistic approach to research that goes beyond standard single or dual agonists. This compound is a primary focus for studies involving significant energy expenditure increases, liver fat reduction, and accelerated weight management. Each vial is processed via state-of-the-art lyophilization to ensure maximum purity and long-term stability for precise laboratory analysis.

Key Features & Research Focus

• Triple-Action Agonist: The most advanced metabolic research peptide currently available.

• Glucagon Integration: Uniquely targets glucagon receptors to study increased caloric burn.

• Ultra-High Purity: HPLC-tested at 99%+ to meet professional lab standards.

• Broad Range Options: Available in concentrations up to 40mg for intensive study protocols.